COMPANY PROFILE

CellFE

Explore full profile

Company developing a microfluidics based device to deliver gene-editing molecules

Alameda, United StatesFounded 2018Biotech & Life Sciences

Valuation $0–100M Latest valuation · 2023

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About CellFE

CellFE is a biotechnology company focused on advancing cell therapies through innovative microfluidic cellular engineering technology. The company serves advanced cell therapy researchers and developers, operating in the biotechnology and healthcare markets. CellFE's business model revolves around providing cutting-edge solutions that enhance the manufacturing process of cell therapies, making them more potent, durable, and cost-effective. Revenue is generated through partnerships, licensing agreements, and direct sales of their proprietary technology. The company is dedicated to supporting cell therapy innovators in producing superior treatments for patients worldwide, leveraging a team of seasoned biotech experts and inventors.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2018
Headquarters: Alameda, United States
Employees: 19
Open positions: None listed
Dealroom signal: 60.3/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Microfluidics, Spinout, Biotech and Pharma, DT and LS, science-based
Links: Website LinkedIn

Latest news

Press, funding announcements and product moves mentioning CellFE.

See all news

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Sep 2023	$22M	$88M	Khosla Ventures · Cota Capital · GreatPoint Ventures · Embark Ventures	↗
SEED✓Equity / VC	Mar 2020	$4.8M	$19M	Dynamk Capital · McEwan Lane Family Trust · Cota Capital · Embark Ventures	—

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

CellFE website traffic

Latest recorded traffic for CellFE is 1.4K monthly website visits, up 40% over the last three months. CellFE's team declined 9.5% over the past year.

Latest monthly visits1.4K 3-month web change+40% 1-year team growth-9.5%

Monthly website visitsDec 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
LSLife SI3D bioprinters and microfluidics systems for healthcare	Argentina	Operational	6	$112K	$200K
JBJavelin BiotechPredictive drug discovery platforms merging human and computational biology to accelerate preclinical drug discovery and improve approval rates	Woburn, United States	Operational
KIKimialysDeveloper of an analytical device intended to offer products based on innovative surface chemistry in the field of biosensors	Paris, France	Operational
UNUniteLabsThe digital infrastructure for a new generation of biotech	Munich, Germany	Operational
HTHiFiBiO TherapeuticsAn emerging clinical stage multinational company mobilizing the human immune system to treat cancer and autoimmune diseases	Cambridge, United States	Operational
MIMimetasDeveloping physiologically relevant 3D human disease models and partnering with global pharmaceutical companies to create therapies for untreatable diseases	Oegstgeest, Netherlands	Acquired
STShanghai Aorui TechnologyMicrofluidic solutions for precision diagnostics and personalized medicine	China	Operational
HTHangzhou Haoli TechnologyMicrofluidic chip company specializing in digital production of life science microsphere materials	China	Operational